State-of-the-Art Monitoring of Cytomegalovirus-Specific Cell-Mediated Immunity After Organ Transplant: A Primer for the Clinician

Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung Transplantation

(2013) Scott M. Palmer   ANNALS OF INTERNAL MEDICINE

Prospective Analysis of Human Cytomegalovirus DNAemia and Specific CD8+ T Cell Responses in Lung Transplant Recipients

(2012) L. Weseslindtner et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Human Cytomegalovirus-Specific T-Cell Immune Reconstitution in Preemptively Treated Heart Transplant Recipients Identifies Subjects at Critical Risk for Infection

(2012) Davide Abate et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Virologic and Immunologic Monitoring of Cytomegalovirus to Guide Preemptive Therapy in Solid-Organ Transplantation

(2011) G. Gerna et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Serum antibody response to the gH/gL/pUL128–131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections

(2011) Emilia Genini et al.   JOURNAL OF CLINICAL VIROLOGY

Primary Cytomegalovirus Phosphoprotein 65–Specific CD8+ T-Cell Responses and T-bet Levels Predict Immune Control During Early Chronic Infection in Lung Transplant Recipients

(2011) Matthew R. Pipeling et al.   JOURNAL OF INFECTIOUS DISEASES

T cell exhaustion

(2011) E John Wherry   NATURE IMMUNOLOGY

Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipients

(2011) Manisha Patel et al.   PEDIATRIC TRANSPLANTATION

Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients

(2011) Corinna La Rosa et al.   TRANSPLANT INTERNATIONAL

Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia

(2011) Luiz F. Lisboa et al.   TRANSPLANTATION

Evaluation and Significance of Cytomegalovirus-Specific Cellular Immune Response in Lung Transplant Recipients

(2011) C. Costa et al.   TRANSPLANTATION PROCEEDINGS

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients

(2010) A. Humar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Evaluation of Cytomegalovirus (CMV)–Specific T Cell Immune Reconstitution Revealed That Baseline Antiviral Immunity, Prophylaxis, or Preemptive Therapy but not Antithymocyte Globulin Treatment Contribute to CMV‐Specific T Cell Reconstitution in Kidney Transplant Recipients

(2010) Davide Abate et al.   JOURNAL OF INFECTIOUS DISEASES

Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study

(2010) Atul Humar et al.   TRANSPLANTATION

International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation

(2010) Camille N. Kotton et al.   TRANSPLANTATION

Monitoring Cytomegalovirus T-Cell Immunity in Small Bowel/Multivisceral Transplant Recipients

(2010) A. Chiereghin et al.   TRANSPLANTATION PROCEEDINGS

Quantiferon-CMV Test in Prediction of Cytomegalovirus Infection After Kidney Transplantation

(2010) A. Lochmanova et al.   TRANSPLANTATION PROCEEDINGS

Cytomegalovirus in Solid Organ Transplant Recipients

(2009) A. Humar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients

(2009) D. Kumar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients

(2009) A. Åsberg et al.   AMERICAN JOURNAL OF TRANSPLANTATION

CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study

(2009) Fredrik Sund et al.   CLINICAL TRANSPLANTATION

Narrowing of T-cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients

(2009) Katherine K Wynn et al.   IMMUNOLOGY AND CELL BIOLOGY

A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection

(2009) Albert J Eid et al.   TRANSPLANT INTERNATIONAL

Experience With Immune Monitoring in Lung Transplant Recipients: Correlation of Low Immune Function With Infection

(2009) Shahid Husain et al.   TRANSPLANTATION

The Number of Activating KIR Genes Inversely Correlates with the Rate of CMV Infection/Reactivation in Kidney Transplant Recipients

(2008) M. Stern et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Linking CMV Serostatus to Episodes of CMV Reactivation Following Lung Transplantation by Measuring CMV-Specific CD8+T-Cell Immunity

(2008) G. P. Westall et al.   AMERICAN JOURNAL OF TRANSPLANTATION

PD-1 Expression and IL-2 Loss of Cytomegalovirus- Specific T Cells Correlates with Viremia and Reversible Functional Anergy

(2008) U. Sester et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Investigation of promoter variations in dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN) (CD209) and their relevance for human cytomegalovirus reactivation and disease after allogeneic stem-cell transplantation

(2008) M. Mezger et al.   CLINICAL MICROBIOLOGY AND INFECTION

Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients

(2008) Adrian Egli et al.   Journal of Translational Medicine